Literature DB >> 15065876

Enhancing the second step of the trans excision-splicing reaction of a group I ribozyme by exploiting P9.0 and P10 for intermolecular recognition.

Michael A Bell1, Joy Sinha, Ashley K Johnson, Stephen M Testa.   

Abstract

We previously reported that a group I intron-derived ribozyme can catalyze the excision of targeted sequences from within RNAs in vitro and that dissociation of the bridge-3' exon intermediate between the two reaction steps is a significant contributing factor to low product yields. We now analyze the effects of increasing the length, and thus the strength, of helices P9.0 and P10, which occur between the ribozyme and the bridge-3' exon region of the substrate, on this trans excision-splicing reaction. Using substrates where lengthy targeted regions are excised, these modifications can significantly increase product yields, specifically by enhancing the second reaction step. A threshold for product formation is obtained, however, at around five base pairs for P10 and eight base pairs for P9.0. Nevertheless, elongating P9.0 appears to be the more effective strategy, as both substrate binding and the rate of the second reaction step increase. In addition, P10 is required when P9.0 is not elongated. Also, a strong P9.0 helix cannot replace a weaker P10 helix, indicating that P9.0 and P10 play somewhat distinct roles in the reaction. We also show that second-step inhibition stems from the formation of an extended P1 helix (P1ex), consisting of as little as a single Watson-Crick base pair, as well as the mere presence of substrate nucleosides immediately downstream from P10. Both of these inhibitory components can be overcome by utilizing P9.0 and P10 elongated ribozymes. This work sets forth an initial framework for rationally designing more effective trans excision-splicing ribozymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065876     DOI: 10.1021/bi035874n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Computational prediction of efficient splice sites for trans-splicing ribozymes.

Authors:  Dario Meluzzi; Karen E Olson; Gregory F Dolan; Gaurav Arya; Ulrich F Müller
Journal:  RNA       Date:  2012-01-24       Impact factor: 4.942

2.  In vivo excision of a single targeted nucleotide from an mRNA by a trans excision-splicing ribozyme.

Authors:  Dana A Baum; Stephen M Testa
Journal:  RNA       Date:  2005-05-04       Impact factor: 4.942

3.  Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells.

Authors:  Pruksa Nawtaisong; Mark E Fraser; James R Carter; Malcolm J Fraser
Journal:  Virology       Date:  2015-04-07       Impact factor: 3.616

4.  Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns.

Authors:  James R Carter; James H Keith; Pradip V Barde; Tresa S Fraser; Malcolm J Fraser
Journal:  BMC Mol Biol       Date:  2010-11-15       Impact factor: 2.946

5.  Effective suppression of dengue virus using a novel group-I intron that induces apoptotic cell death upon infection through conditional expression of the Bax C-terminal domain.

Authors:  James R Carter; James H Keith; Tresa S Fraser; James L Dawson; Cheryl A Kucharski; Kate M Horne; Stephen Higgs; Malcolm J Fraser
Journal:  Virol J       Date:  2014-06-13       Impact factor: 4.099

Review 6.  Design and Experimental Evolution of trans-Splicing Group I Intron Ribozymes.

Authors:  Ulrich F Müller
Journal:  Molecules       Date:  2017-01-02       Impact factor: 4.411

7.  Fitness landscape of a dynamic RNA structure.

Authors:  Valerie W C Soo; Jacob B Swadling; Andre J Faure; Tobias Warnecke
Journal:  PLoS Genet       Date:  2021-02-01       Impact factor: 5.917

8.  Tetrahymena thermophila and Candida albicans group I intron-derived ribozymes can catalyze the trans-excision-splicing reaction.

Authors:  P Patrick Dotson; Ashley K Johnson; Stephen M Testa
Journal:  Nucleic Acids Res       Date:  2008-08-06       Impact factor: 16.971

9.  Spliceozymes: ribozymes that remove introns from pre-mRNAs in trans.

Authors:  Zhaleh N Amini; Karen E Olson; Ulrich F Müller
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.